Loading clinical trials...

Postpartum Weight Loss for Women at Elevated Cardiovascular Risk | Clinical Trials | Clareo Health

COMPLETEDNA

Postpartum Weight Loss for Women at Elevated Cardiovascular Risk

Postpartum Weight Loss for Women at Elevated Cardiovascular Risk (EmPOWER-Mom Study)

NCT04914819•University of Pennsylvania

Summary

The aim of this study is to test the feasibility and effectiveness of a 16-week online behavioral weight loss program compared to usual care to promote weight loss in the postpartum period among women with cardiovascular risk factors. The investigators will also be testing different behavioral strategies to recruit postpartum women to the study, including 2 email recruitment strategies and 2 mailer recruitment strategies, informed by behavioral design.

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•1. Age ≥18 years;
•2. Delivered a baby at HUP or PAH within 3-12 months prior to study start;
•3. BMI ≥ 27 kg/m2
•4. Diagnosis of one of the following medical conditions: chronic hypertension, gestational hypertension, preeclampsia, eclampsia, gestational diabetes, or diabetes mellitus (type 1 or 2) based on diagnosis codes in the EMR
•5. Has online access through smartphone or computer and has email address
•6. Ability to read and provide informed consent to participate in the study

Exclusion Criteria

•1. Delivered prior to 32 weeks gestation in the EMR
•2. Documentation of fetal demise or neonatal demise in the EMR
•3. Currently pregnant or planning to get pregnant within the next 5 months
•4. Does not speak English
•5. Answers yes to any of the following questions:
•* Are you currently participating in any other weight loss or physical activity studies?
•* Do you have any medical conditions or other reasons why you could not participate in a 16-week weight loss or physical activity program?
•6. Participants will be excluded after completing the run-in period if they do not complete the daily food log or their baseline BMI is \< 27 kg/m2

Locations (1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Key Dates

Start Date

June 18, 2021

Primary Completion Date

December 31, 2021

Completion Date

December 31, 2021

Last Updated

July 6, 2023

Enrollment

ACTUAL participants

Conditions

Weight LossPostpartum Weight RetentionHypertension in PregnancyDiabetes Mellitus in PregnancyPreeclampsiaRecruitment

Interventions

Online Behavioral Weight Loss Program

BEHAVIORAL

Virtual weigh-in

BEHAVIORAL

Protein Supplementation Intervention on Body Weight

NCT06989203

ObesityWeight Loss+1 more

View study

RECRUITINGPHASE3

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

NCT07104383

Weight Loss

View study

RECRUITINGNA

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 6, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Postpartum Weight Loss for Women at Elevated Cardiovascular Risk

Inclusion Criteria

Exclusion Criteria

Protein Supplementation Intervention on Body Weight

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

Dyad Plus Effectiveness/Feasibility

Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults